Skip to main content

Burcon updates on Peazazz® and Multiple Patent Grants

 

Clinical courses

 

Clinical research courses

Burcon NutraScience Corporation is pleased to announce that it has been granted a U.S. patent, covering technology for the production of its Peazazz® pea protein:  U.S. patent no. 9,635,875, was granted on May 2, 2017.  This patent is the first to be granted for Burcon’s pea technology by the United States Patent and Trademark Office and confirms that the Company’s approach is unique, distinct and defensible.  Burcon anticipates further positive progress, with its patent filings, in due course.

Burcon also announces that it has been granted two more U.S. patents covering technologies for the production of CLARISOY™, and it has also received two notices of allowance from the United States Patent and Trademark Office for two more patents for the production of CLARISOY™ soy protein.  A notice of allowance from the United States Patent and Trademark Office is a written notification that a patent application has cleared internal review, is pending issuance and will grant in the near future.  CLARISOY™ soy protein patents: U.S. patent no. 9,629,381 was granted April 25, 2017; and U.S. patent no. 9,603,377 was granted on March 28, 2017; and U.S. patent application 15/094386 was allowed on March 14, 2017, and U.S. patent application 14/117384 was allowed on March 29, 2017.

The five U.S. patent grants and allowances, as announced above, bring the company’s patent portfolio to over 215 issued patents in various countries, including 65 in the U.S., as well as over 350 active patent applications, including 47 additional U.S. patent applications.

 

Also, during the first part of 2017, Burcon continued its efforts toward commercializing its other unique plant protein extraction technologies. Burcon has focused in particular on working with a select group of potential partners in the commercialization process for our Peazazz® pea protein. The team at the Winnipeg Technical Centre continues to support these ongoing discussions with: due diligence visits; applications work; and sample production. The potential partners’ activities have included undertaking applications work, detailed market analyses and the investigation of production logistics.

"The interest in, and need for, alternative plant protein ingredients continue to be a major trend within the food, beverage and nutritional products industries," said Johann Tergesen, Burcon’s president and chief operating officer, adding, “We are thrilled to see Burcon’s novel plant proteins progressing toward full commercialization and are confident of our ability to profit from this major trend.”

<< Back to Pharma News

Subscribe to PharmaTutor News Alerts by Email